Nouveau Life Pharmaceuticals Inc (NOUV)
OTHER OTC:NOUV
US Market
Holding NOUV?
Track your performance easily

Nouveau Life Pharmaceuticals (NOUV) Financial Statements

28 Followers

Nouveau Life Pharmaceuticals Financial Overview

Nouveau Life Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Nouveau Life Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 08Dec 07Sep 07Jun 07Mar 07
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -125.57K$ -112.25K$ -118.84K$ -146.66K$ -68.91K
EBITDA$ -44.74K$ -73.20K$ -79.87K$ -37.78K$ -47.91K
Net Income Common Stockholders$ -125.57K$ -112.25K$ -118.84K$ -146.66K$ -68.91K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 347.00$ 252.00$ 1.52K$ 3.96K$ 2.07K
Total Assets$ 1.17M$ 1.25M$ 1.29M$ 1.33M$ 1.39M
Total Debt$ 64.54K$ 387.81K$ 70.42K$ 67.77K$ 45.87K
Net Debt$ 64.19K$ 387.56K$ 68.90K$ 63.81K$ 43.80K
Total Liabilities$ 1.13M$ 1.11M$ 1.07M$ 1.01M$ 974.83K
Stockholders Equity$ 42.69K$ 138.22K$ 223.39K$ 315.86K$ 415.87K
Cash Flow-
Free Cash Flow$ 3.42K$ -143.00$ -6.43K$ -19.54K$ -2.37K
Operating Cash Flow$ 3.42K$ -143.00$ -5.25K$ -19.54K$ -2.37K
Investing Cash Flow$ 0.00$ 0.00$ -1.18K$ 0.00$ 0.00
Financing Cash Flow$ -1.43K$ -1.55K$ 1.60K$ 17.70K$ 3.37K
Currency in USD

Nouveau Life Pharmaceuticals Earnings and Revenue History

Nouveau Life Pharmaceuticals Debt to Assets

Nouveau Life Pharmaceuticals Cash Flow

Nouveau Life Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis